re:regenerative medicine spark skin cell banki, page-34

so long termers, i have been through 6years annual reports,last few quarterlies, some ann.s, the substantial notices, teh Wilson broker report, the website and some HC posts (phew there's a lot of you)...theres much to like especially high margin, teh increasing sales and the now slower cash burn and the fact its proven and nascent...

can't figure why more directors notices haven't popped up, last one a year ago....and i see Dr Wood initially had 6mil odd many years ago.

The IP transfer conveniently done before getting onto OTC.

so couple questions:
- do I need to check out TIS.AX as a competitor?
- is the claim by Hong Kong partner of concern?

very stong 2 month SP performance but will it be enough to replace the stale holders from last few years

also i like the the fact that they have chewed through $91m (retained earnings) to get to where it is today shows that todays $64M m.cap is still "cheapish."